Skip to main content

Promega, SABiosciences Partner on Pathway Assay Technologies

NEW YORK (GenomeWeb News) – Promega today said that it and SABiosciences will combine their research tools for interrogating specific cellular pathways via transcription factor reporters.

Under the deal, Promega's recombinant firefly luciferase luc2 gene and a humanized Renilla luciferase (hRluc) gene will serve as one key reporter system for SABiosciences' Cignal pathway reporter assays.

Dave Martz, VP of sales and marketing for SABiosciences, said in a statement that Promega's luciferase reporters "provide the necessary levels of sensitivity for studying the effects of drugs or genetic perturbations on many interesting and biologically relevant cell types."

Terms of the alliance were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.